X4 Pharmaceuticals (XFOR) EPS (Diluted) (2020 - 2025)
X4 Pharmaceuticals (XFOR) EPS (Diluted) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn | 0.15 |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 0.00 |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn | 7.33 |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 1.49 |
| 10 | X4 Pharmaceuticals | 166.21 Mn | -50.84 Mn | 2.20 Mn | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | -0.69 |
| Jun 30, 2025 | -3.47 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -5.94 |
| Sep 30, 2024 | -5.47 |
| Jun 30, 2024 | 13.57 |
| Mar 31, 2024 | -7.77 |
| Dec 31, 2023 | -3.23 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -9.91 |
| Mar 31, 2023 | -4.94 |
| Dec 31, 2022 | -13.75 |
| Sep 30, 2022 | -7.89 |
| Jun 30, 2022 | -17.96 |
| Mar 31, 2022 | -21.54 |
| Dec 31, 2021 | -41.84 |
| Sep 30, 2021 | -22.75 |
| Jun 30, 2021 | -29.35 |
| Mar 31, 2021 | -40.22 |